Immuron’s Technology Platform of Treatments in the Age of the Coronavirus OutbreakGlobeNewsWire • 02/03/20
Immuron Receives $3.7M In Federal Dollars For Traveler's Diarrhea Preventative Therapy ProjectBenzinga • 10/02/19
New U.S. Department of Defense Research Collaboration with Immuron to Develop and Clinically evaluate a New Therapeutic against CampylobacterGlobeNewsWire • 10/02/19
U.S. Defense Reports Immuron’s Travelan® demonstrates broad reactivity to Vibrio cholera strains from Southeast Asia indicating broad potential for prevention of travelers’ diarrheaGlobeNewsWire • 09/04/19